Scopus BioPharma Inc. (NasdaqGM:SCPS) entered into an agreement to acquire Olimmune Inc. for $14.3 million on June 25, 2021. The consideration paid Scopus issued to Olimmune stockholders 1,000,000 shares of common stock of the Company. We also issued 100,000 shares of common stock of the Company to City of Hope as additional consideration for the two license agreements. Scopus BioPharma Inc. (NasdaqGM:SCPS) completed the acquisition of Olimmune Inc. on June 25, 2021.